ROBERT S KAUFMANN
Allopathic & Osteopathic Physicians|Internal Medicine ATLANTA, GA NPI 1376573147
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine GA ABBVIE INC. All categories
General Payments — all program years on this page
$25,662.77
- Category: General Payments
- Program years: PY2018–2024
- Record count: 828
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,187.03 across 66 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,187.03 | 66 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $180.11 | 12 |
| Abbott Laboratories | $138.71 | 7 |
| Novo Nordisk AS | $134.58 | 8 |
| Lilly USA, LLC | $65.35 | 4 |
| GlaxoSmithKline, LLC. | $60.12 | 3 |
| Amgen Inc. | $52.72 | 3 |
| IRONWOOD PHARMACEUTICALS, INC | $51.94 | 3 |
| Acerta Pharma LLC | $50.78 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $44.16 | 2 |
| Tris Pharma Inc | $41.95 | 2 |
| AIMMUNE THERAPEUTICS, INC. | $39.00 | 2 |
| IRONSHORE PHARMACEUTICALS INC. | $38.77 | 2 |
| Astellas Pharma US Inc | $34.79 | 2 |
| Genentech USA, Inc. | $31.69 | 1 |
| Gilead Sciences, Inc. | $27.05 | 1 |
| Noven Therapeutics, LLC | $22.50 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $19.90 | 1 |
| Exact Sciences Corporation | $19.85 | 1 |
| Neos Therapeutics, LP | $18.05 | 1 |
| Phathom Pharmaceuticals, Inc. | $17.76 | 1 |
| DEXCOM, INC. | $17.36 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $16.43 | 1 |
| Merck Sharp & Dohme Corporation | $16.34 | 1 |
| Janssen Pharmaceuticals, Inc | $16.06 | 1 |
| Azurity Pharmaceuticals, Inc. | $15.74 | 1 |
| Esperion Therapeutics, Inc. | $15.32 | 1 |
By program year
Records — PY2024 (66)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.